Ibiglustat succinate

SI-6987

Ibiglustat succinate, >98% (HPLC)

CAS No. : [1629063-80-4]

Synonyms : Venglustat succinate; SAR-402671 succinate; GZ-402671 succinate

IUPAC Name : (S)-Quinuclidin-3-yl (2-(2-(4-fluorophenyl)thiazol-4-yl)propan-2-yl)carbamate succinate

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
5MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
10MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
25MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
50MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
100MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026

Applications : Ibiglustat succinate, the succinate salt of Venglustat, functions as a potent, orally active, and brain‑penetrant GCS inhibitor. Its pharmacological profile supports its use across multiple glycosphingolipid‑related disorders, including Gaucher disease type 3, GBA‑linked Parkinson’s disease, Fabry disease, GM2 gangliosidosis, and autosomal dominant polycystic kidney disease.

References : Viel C. et al.: Sci. Rep., 11(1), 20945, 2021; Peterschmitt M. J. et al.: Clin. Pharmacol. Drug Dev., 10(1), 86-98, 2021; Iva Stojkovska. et al.: Cell Tissue Res., 2017; Itier J. M. et al.: J. Inherit. Metab. Dis., 37(6), 1013-1022, 2014.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.